Akebia Therapeutics
AKBA
#7054
Rank
NZ$0.66 B
Marketcap
$3.06
Share price
0.28%
Change (1 day)
80.09%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: NZ$0.66 Billion

As of November 2024 Akebia Therapeutics has a market cap of NZ$0.66 Billion. This makes Akebia Therapeutics the world's 7054th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.66 B80.95%
2023NZ$0.36 B120.95%
2022NZ$0.16 B-71.12%
2021NZ$0.57 B3.21%
2020NZ$0.56 B-50.88%
2019NZ$1.14 B18.49%
2018NZ$0.96 B-2.63%
2017NZ$0.98 B71.84%
2016NZ$0.57 B-0.5%
2015NZ$0.57 B91.27%
2014NZ$0.30 B

End of Day market cap according to different sources

On Nov 18th, 2024 the market cap of Akebia Therapeutics was reported to be:

NZ$0.66 Billion
by Nasdaq info icon info icon
NZ$0.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$259.60 B 38,738.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$350.19 B 52,290.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$622.16 B 92,978.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.32 B-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA